Meredyth Wilkinson

6PUBLICATIONS
52CO-AUTHORS
AutoimmunityMedical infection agents (incl. prions)Pacific Peoples youth and familyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 25, 2024
Type I interferon and mitochondrial dysfunction are associated with dysregulated cytotoxic CD8+ T cell responses in juvenile systemic lupus erythematosus.

Anna Radziszewska, Hannah Peckham, Restuadi Restuadi

|May 15, 2023
Juvenile idiopathic inflammatory myositis: an update on pathophysiology and clinical care.

Charalampia Papadopoulou, Christine Chew, Meredyth G Ll Wilkinson

|Dec 23, 2022
Role of CD14+ monocyte-derived oxidised mitochondrial DNA in the inflammatory interferon type 1 signature in juvenile dermatomyositis.

Meredyth G Ll Wilkinson, Dale Moulding, Thomas C R McDonnell

|Sep 26, 2021
JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology.

Meredyth G Ll Wilkinson, Claire T Deakin, Charalampia Papadopoulou

|Sep 20, 2021
A survey to understand the feelings towards and impact of COVID-19 on the households of juvenile dermato myositis patients from a parent or carer perspective.

Meredyth Grace Llewellyn Wilkinson, Wing Wu, Kathryn O'Brien

|Nov 07, 2020
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans.

Kevin W Ng, Nikhil Faulkner, Georgina H Cornish

Pageof 1